Furthermore, the McIlroy and Rochford groups have restored human BSCL2 expression in global Bscl2-KO mice via AAV, which improved lipodystrophy-associated metabolic issues, an exciting application of gene therapy in lipodystrophy (59, 60). The gene discussed is BSCL2; the disease is lipodystrophy.